Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1956 1
1957 4
1958 1
1961 1
1964 6
1965 9
1966 2
1967 1
1968 1
1969 2
1970 1
1971 3
1972 4
1973 5
1975 2
1976 2
1977 1
1978 3
1979 2
1980 5
1981 2
1982 4
1983 4
1984 2
1985 1
1986 3
1987 2
1988 3
1989 3
1992 1
1993 2
1994 5
1995 4
1996 2
1997 2
1998 3
1999 5
2000 6
2001 14
2002 10
2003 8
2004 4
2005 17
2006 30
2007 35
2008 50
2009 46
2010 40
2011 44
2012 58
2013 69
2014 59
2015 63
2016 79
2017 71
2018 75
2019 89
2020 102
2021 114
2022 133
2023 129
2024 131
2025 132
2026 88

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,580 results

Results by year

Filters applied: . Clear all
Page 1
Phase 2 test of QBS72S for breast cancer leptomeningeal disease.
Nagpal S, Carlson-Clarke B, Rout SS, Trinh TTH, Roy-O'Reilly M, Tedjakusuma SN, Taiwo R, Harary PM, Granucci M, Chernikova SB, Bertrand S, Therkelsen KE, Han SS, Gu B, Bharani KL, Newman JM, Barisano G, Umeh-Garcia MC, Herrick D, Vogel H, Arora M, Samos CH, Soltys SG, Pollom EL, Rahimy E, Iv M, Melisko ME, Hayden Gephart M. Nagpal S, et al. Among authors: arora m. Neuro Oncol. 2026 Aug 7:noag177. doi: 10.1093/neuonc/noag177. Online ahead of print. Neuro Oncol. 2026. PMID: 42565554
Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk ERBB2-Negative Breast Cancer: The I-SPY2 Randomized Clinical Trial.
Isaacs C, Nanda R, Yau C, Chien AJ, Hershman DL, Stringer-Reasor EM, Wallace AM, Thomas A, Vaklavas C, Clark AS, Kennedy LC, Sanford A, Boughey JC, Albain KS, Pusztai L, Kalinsky KM, Beckwith H, Williams NO, Han HS, Falkson C, Arora M, Elias AD, Pohlmann PR, Rozenblit M, Marshall N, Chen YY, Trivedi MS, McGuinness JE, Howard FM, Chen N, Khoury K, Lancaster RB, Yeung KT, Douglas E, Wei M, Mainor C, LeStage B, Delson AL, Asare AL, Brown-Swigart L, Hirst GL, Matthews JB, Perlmutter J, Symmans WF, Yee D, Hylton NM, van 't Veer LJ, Rugo HS, DeMichele AM, Berry DA, Esserman LJ. Isaacs C, et al. Among authors: arora m. JAMA Oncol. 2026 Jul 30:e262576. doi: 10.1001/jamaoncol.2026.2576. Online ahead of print. JAMA Oncol. 2026. PMID: 42530945
Allogenic Hematopoietic Stem Cell Transplantation in Children With Transfusion Dependent Thalassemia Using Treosulfan-Thiotepa-Fludarabine Based Conditioning.
Arora S, Chakraborty S, Panda NR, Nathany S, Chadha V, Batra S, Singh PP, Arora M, Swaminathan A, Pokhriyal S, Sharma B, Bhargava R, Dua V. Arora S, et al. Among authors: arora m. J Pediatr Hematol Oncol. 2026 Jul 14. doi: 10.1097/MPH.0000000000003246. Online ahead of print. J Pediatr Hematol Oncol. 2026. PMID: 42467967
1,580 results